시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 AHA(Alpha Hydroxy Acid) 시장 보고서(2025년)
Alpha Hydroxy Acid Global Market Report 2025
상품코드 : 1702733
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,219,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,990,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,761,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

AHA(Alpha Hydroxy Acid) 시장은 의료비 지출 증가로 인해 성장할 것으로 예상됩니다. 의료비 지출은 3,634억 4,000만 달러(2,807억 파운드)로 증가했으며, 1인당 평균 지출은 5,422달러(4,188 파운드)가 되었습니다.

AHA(Alpha Hydroxy Acid) 주요 시장 진출기업은 Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis International AG, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Mylan NV, Bausch Health Companies Inc., Intas Pharmaceuticals Ltd., Apotex Inc. 등입니다.

2024년 AHA(Alpha Hydroxy Acid) 시장에서 가장 규모가 큰 지역은 북미였습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별,국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Alpha methyldopa, often written as a-methyldopa, is a medication primarily used to manage high blood pressure (hypertension) by affecting the central nervous system. It lowers blood pressure and reduces certain chemicals in the body that narrow blood vessels. Alpha methyldopa is also prescribed to treat specific conditions during pregnancy, such as preeclampsia.

The main types of alpha (a) methyldopa include oral and intravenous formulations. Oral alpha methyldopa is taken by mouth and acts as a central alpha-2 adrenergic agonist to treat high blood pressure. It is available in various purity levels, such as purity >=98% and purity >=99%, and has additional applications in conditions such as parkinsonism and hepatic coma.

The alpha (a) methyldopa market research report is one of a series of new reports from The Business Research Company that provides alpha (a) methyldopa market statistics, including the alpha (a) methyldopa industry's global market size, regional shares, competitors with an alpha (a) methyldopa market share, detailed alpha (a) methyldopa market segments, market trends and opportunities, and any further data you may need to thrive in the alpha (a) methyldopa industry. This alpha (a) methyldopa market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The alpha hydroxy acid market size has grown rapidly in recent years. It will grow from $1.49 billion in 2024 to $1.64 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rising awareness of skincare, advancements in cosmetic science, the popularity of anti-aging products, and the expansion of the beauty and wellness industry.

The alpha hydroxy acid market size is expected to see rapid growth in the next few years. It will grow to $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for personalized skincare, growth in premium beauty products, expanding e-commerce platforms, and innovations in AHA formulations. Major trends in the forecast period include a shift toward natural and organic products, a focus on multifunctional products, increasing use of professional treatments, the rising popularity of at-home skincare devices, and technological advancements.

The a-methyldopa market is poised for growth due to increasing cases of hypertension. Hypertension, or high blood pressure, results from factors such as poor diet, lack of physical activity, obesity, and elevated stress levels. a-Methyldopa effectively treats hypertension by lowering specific chemicals in the blood, promoting blood vessel relaxation and reducing blood pressure. For example, the Heart Foundation reported in January 2024 that about 23% of adults in Australia have hypertension, with a higher prevalence among men (25%) than women (22%). This trend is expected to drive demand for a-methyldopa.

The a-methyldopa market is also expected to expand due to the growing preference for generic drugs. Generic medications are cost-effective alternatives to brand-name drugs, offering equivalent quality, performance, and safety. a-Methyldopa, as a widely used generic medication for hypertension management, particularly benefits groups such as pregnant women. The U.S. Food and Drug Administration noted in 2023 that generics constitute approximately 90% of the prescription drug market volume in the U.S., reflecting widespread adoption also seen in countries such as the U.K., Australia, China, and Germany. This preference for generics is anticipated to bolster the a-methyldopa market.

The a-methyldopa market is expected to grow due to rising healthcare expenditure. Healthcare expenditure, encompassing spending on healthcare goods and services, is increasing globally due to aging populations, higher incidence of chronic diseases, and greater demand for healthcare services and medications. For instance, in the UK, healthcare spending rose to $363.44 billion (£280.7 billion) in 2021, with an average expenditure of $5422 (£4,188) per person. This increased funding for healthcare services is set to drive demand for a-methyldopa and other hypertension treatments, underscoring its growth potential in the market.

Major companies operating in the alpha (a) methyldopa market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis International AG, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Mylan N.V., Bausch Health Companies Inc., Intas Pharmaceuticals Ltd., Apotex Inc., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Wockhardt Ltd., Laboratoires Confab, Globela Pharma Pvt. Ltd., Pro Doc Ltee, AA Pharma inc., LGM Pharma

North America was the largest region in the a-Methyldopa market in 2024. The regions covered in the alpha (a) methyldopa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alpha (a) methyldopa market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alpha (a) methyldopa market consists of sales of extended-release tablets, and combination tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alpha Hydroxy Acid Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alpha hydroxy acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for alpha hydroxy acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alpha hydroxy acid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Alpha Hydroxy Acid Market Characteristics

3. Alpha Hydroxy Acid Market Trends And Strategies

4. Alpha Hydroxy Acid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Alpha Hydroxy Acid Growth Analysis And Strategic Analysis Framework

6. Alpha Hydroxy Acid Market Segmentation

7. Alpha Hydroxy Acid Market Regional And Country Analysis

8. Asia-Pacific Alpha Hydroxy Acid Market

9. China Alpha Hydroxy Acid Market

10. India Alpha Hydroxy Acid Market

11. Japan Alpha Hydroxy Acid Market

12. Australia Alpha Hydroxy Acid Market

13. Indonesia Alpha Hydroxy Acid Market

14. South Korea Alpha Hydroxy Acid Market

15. Western Europe Alpha Hydroxy Acid Market

16. UK Alpha Hydroxy Acid Market

17. Germany Alpha Hydroxy Acid Market

18. France Alpha Hydroxy Acid Market

19. Italy Alpha Hydroxy Acid Market

20. Spain Alpha Hydroxy Acid Market

21. Eastern Europe Alpha Hydroxy Acid Market

22. Russia Alpha Hydroxy Acid Market

23. North America Alpha Hydroxy Acid Market

24. USA Alpha Hydroxy Acid Market

25. Canada Alpha Hydroxy Acid Market

26. South America Alpha Hydroxy Acid Market

27. Brazil Alpha Hydroxy Acid Market

28. Middle East Alpha Hydroxy Acid Market

29. Africa Alpha Hydroxy Acid Market

30. Alpha Hydroxy Acid Market Competitive Landscape And Company Profiles

31. Alpha Hydroxy Acid Market Other Major And Innovative Companies

32. Global Alpha Hydroxy Acid Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alpha Hydroxy Acid Market

34. Recent Developments In The Alpha Hydroxy Acid Market

35. Alpha Hydroxy Acid Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기